Global Contrast Enhanced Ultrasound Market Growth (Status and Outlook) 2023-2029

Global Contrast Enhanced Ultrasound Market Growth (Status and Outlook) 2023-2029

The global Contrast Enhanced Ultrasound market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Contrast Enhanced Ultrasound is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Contrast Enhanced Ultrasound is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Contrast Enhanced Ultrasound is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Contrast Enhanced Ultrasound players cover Trivitron Healthcare, Bracco Diagnostic Inc., Koninklijke Philips N.V., B.K.Medical Holding Company, Inc., Lantheus Medical lmaging, Inc., GE Healthcare, Daiichi Sankyo Company,Limited, Bristol-Myers Squibb Company and Acusphere, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Contrast-enhanced ultrasound (CEUs) is referred to the application of traditional medical sonography to ultrasoundcontrast medium. Ultrasound contrast agents rely on the different ways in which sound waves are reflected frominterfaces between substances and this may be the surface of a bubble or a more complex structure.

LPI (LP Information)' newest research report, the “Contrast Enhanced Ultrasound Industry Forecast” looks at past sales and reviews total world Contrast Enhanced Ultrasound sales in 2022, providing a comprehensive analysis by region and market sector of projected Contrast Enhanced Ultrasound sales for 2023 through 2029. With Contrast Enhanced Ultrasound sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast Enhanced Ultrasound industry.

This Insight Report provides a comprehensive analysis of the global Contrast Enhanced Ultrasound landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast Enhanced Ultrasound portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contrast Enhanced Ultrasound market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast Enhanced Ultrasound and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast Enhanced Ultrasound.

This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Enhanced Ultrasound market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Non-Targeted Contrast Enhanced Ultrasound
Targeted Contrast Enhanced Ultrasound

Segmentation by application
Hospital
Clinic
Nursing Home

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Trivitron Healthcare
Bracco Diagnostic Inc.
Koninklijke Philips N.V.
B.K.Medical Holding Company, Inc.
Lantheus Medical lmaging, Inc.
GE Healthcare
Daiichi Sankyo Company,Limited
Bristol-Myers Squibb Company
Acusphere, Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.